MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IAM
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Iambic Therapeutics (IAM) Ownership - Who owns Iambic Therapeutics?

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Financial Conglomerates
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.23M
P/E Ratio
N/A
Total Cash
1.54M
Projected Growth
N/A
Total Debt
1.19M
Revenue
23.93K
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for IAM
Related Blogs
TCRT

SHFS vs TCRT: Two Micro-Cap Stories with Diverging Catalysts

TCRT

FRMI vs TCRT: Contrasting High-Volatility Plays in AI Power and Biotech

CDT

CDT vs FMFC: Contrasting Two Nasdaq-Listed Micro-Caps

LQDA

CDT vs LQDA: Weighing an Early-Stage Platform Against a Commercial Biopharma

SLS

Why Is SELLAS Life Sciences Group (SLS) Stock Down -10.93% Today?

View all blogs related to
#Biotechnology
Interesting Articles

What are Double and Triple ETFs?

Which is Better for Me – a Roth or Regular 401(k)?

What is Intrinsic Value?

What is Life Insurance?

Can Blockchains Reduce Fraud and Failed Payments?

View all articles
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry Biotechnology

Industry
Financial Conglomerates
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Who owns Iambic Therapeutics? IAM symbol Ownership - Tickeron.com